Skip to content
Open access

Genetic prediction of colorectal cancer risk in six major ancestries provides insights to streamline practice screening guidelines.

Aug 2026 · medRxiv · 0 citations
Medicine

TL;DR

A comprehensive genetic prediction of CRC risk provides insights that could streamline screening and prevention guidelines and was strongly associated with early onset CRC risk.

Abstract

Background and objective: Colorectal cancer (CRC) is the third leading cause of cancer deaths worldwide. Early identification of high-risk individuals allows targeted prevention and early detection. Design: We constructed a polygenic risk score (PRS) for CRC risk using data from 1,448,354 individuals (103,401 cases). We evaluated its performance for identifying high-risk individuals in 6 major ancestries. Results: The PRS was strongly associated with CRC risk in Europeans (OR per SD =2.13, 95%CI=1.98-2.28), Africans (OR=1.35, 95%CI=1.11-1.64), Hispanics (OR=1.97, 95%CI =1.48-2.61), East Asians (OR=1.98, 95%CI=1.35-2.91), South Asians (OR=1.85, 95%CI=1.44 -2.37), and Middle Easterners (OR=3.10, 95%CI=1.38-6.95). Europeans in the top 10% genetic risk had 14-fold and 5-fold higher CRC risks compared to the bottom 10% (OR=13.50, 95%CI=8.67-21.00), and average (20-70%) risk groups (OR=4.64, 95%CI=3.89-5.52), respectively. The CRC risk in the top 10% individuals was equivalent to having three affected first degree relatives with CRC diagnosed at any age. Genetically high-risk individuals developed CRC up to 15 years earlier than the average. The PRS was strongly associated with early onset CRC risk e.g. in AFR (OR=3.22, 95%CI=1.79-5.81), and improved its prediction e.g. by 9% beyond clinical predictors in EUR. Conclusion: A comprehensive genetic prediction of CRC risk provides insights that could streamline screening and prevention guidelines.

Read PDF

Similar papers

Open access Aug 2026

Using polygenic risk scores to refine risk and outcomes in high-grade serous ovarian cancer in Australia.

BACKGROUND Ovarian cancer is characterised by high mortality and lacks effective screening, making prevention critical. Polygenic risk scores (PRS), which aggregate the effects of multiple common alleles, may capture a proportion of currently unexplained genetic risk. While PRS have been evaluated for risk prediction,...

Rachel Delahunty, S. M. Silva, A. Pandey et al. · 0 citations
Sep 2026

Predicting pancreatic cancer in high-risk individuals and in the general population: how long is the road yet?

Pancreatic ductal adenocarcinoma (PDAC) remains a significant global health burden, projected to become the second leading cause of cancer-related mortality in the Western world by 2030. Due to the lack of effective population-wide screening methods, targeted surveillance of high-risk individuals-those with a lifetime...

D. Campa, C. Rizzato, A. Kataki et al. · 0 citations
Review Sep 2026

Screening strategies for colorectal cancer: adjusting for individual risk factors.

INTRODUCTION Colorectal cancer (CRC) is a common cause of cancer-related mortality. While overall incidence has declined, certain populations - particularly younger patients - have experienced a rise. This suggests a more complex risk profile than the dichotomous average vs high risk delineated in guidelines. Risk is c...

Kelsey L. Anderson, Sophie Montgomery, Ashlee Winslow et al. · 0 citations
Open access Sep 2026

Genetic risk stratification of common diseases in breast cancer survivors: a population-based cohort study.

IMPORTANCE Patients diagnosed with breast cancer (BCa) are at increased risk of multiple common diseases; however, the spectrum of these diseases and the contribution of inherited genetic susceptibility remain incompletely characterized. METHODS We evaluated 15 common diseases and tested their associations with BCa e...

Annabelle Ashworth, Zhu-Qing Shi, Huy Tran et al. · 0 citations
Open access Aug 2026

Age-stratified mutation patterns in early-onset colorectal cancer reveal distinct molecular features and therapeutic implications

Background Colorectal cancer (CRC) is increasingly diagnosed in younger adults, with evidence that early-onset cases (age <50 years) differ in the spectrum of prevalent gene mutations compared with older individuals. To evaluate how these age-related differences may inform testing guidelines and therapeutic development...

L. Liu, A. Rose, A. Samaddar et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.